Atezolizumab (atezo) in platinum-treated locally advanced or metastatic urothelial carcinoma (mUC): Outcomes by prior therapy Meeting Abstract
| Authors: | v. Amsberg, G.; Perez-Garcia, J. L.; Loriot, Y.; Rosenberg, J. E.; Powles, T.; Necchi, A.; Hussain, S. A.; Morales-Barrera, R.; Retz, M.; Niegisch, G.; Duran, I.; Theodore, C.; Grande, E.; Thastrom, A. C.; Li, S.; Abidoye, O. O.; Van Der Heijden, M. S.; on behalf of Lunenburg Lymphoma Phase I/II Consortium (LLPC) |
| Abstract Title: | Atezolizumab (atezo) in platinum-treated locally advanced or metastatic urothelial carcinoma (mUC): Outcomes by prior therapy |
| Meeting Title: | Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie |
| Journal Title: | Oncology Research and Treatment |
| Volume: | 40 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2017 Sep 29-Oct 3 |
| Meeting Location: | Stuttgart, Germany |
| ISSN: | 2296-5270 |
| Publisher: | S. Karger AG |
| Date Published: | 2017-09-01 |
| Start Page: | 115 |
| Language: | English |
| ACCESSION: | WOS:000411428400286 |
| PROVIDER: | wos |
| PUBMED: | 28934740 |
| DOI: | 10.1159/000479566 |
| Notes: | Meeting Abstract: V422 -- Source: Wos |
